Bank of Montreal’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $727K | Buy |
8,911
+616
| +7% | +$44.5K | ﹤0.01% | 2258 |
|
|
2026
Q1 | $565K | Buy |
8,295
+2,476
| +43% | +$175K | ﹤0.01% | 2333 |
|
|
2025
Q4 | $442K | Buy |
+5,819
| New | +$423K | ﹤0.01% | 2370 |
|
|
2024
Q4 | – | Sell |
-216,344
| Closed | -$8.13M | – | 3863 |
|
|
2024
Q3 | $8.13M | Buy |
216,344
+161,362
| +293% | +$5.4M | ﹤0.01% | 1126 |
|
|
2024
Q2 | $1.98M | Buy |
+54,982
| New | +$1.78M | ﹤0.01% | 1667 |
|
|
2023
Q2 | – | Sell |
-4,632
| Closed | -$231K | – | 4238 |
|
|
2023
Q1 | $231K | Buy |
+4,632
| New | +$212K | ﹤0.01% | 2929 |
|
|
2021
Q4 | – | Sell |
-27,213
| Closed | -$1.01M | – | 3793 |
|
|
2021
Q3 | $1.01M | Sell |
27,213
-2,934
| -10% | -$121K | ﹤0.01% | 2489 |
|
|
2021
Q2 | $1.27M | Sell |
30,147
-9,251
| -23% | -$396K | ﹤0.01% | 2337 |
|
|
2021
Q1 | $1.9M | Sell |
39,398
-23,995
| -38% | -$1.42M | ﹤0.01% | 1825 |
|
|
2020
Q4 | $4.2M | Sell |
63,393
-18,517
| -23% | -$1.09M | ﹤0.01% | 1490 |
|
|
2020
Q3 | $4.07M | Sell |
81,910
-6,376
| -7% | -$314K | ﹤0.01% | 1327 |
|
|
2020
Q2 | $5.02M | Buy |
88,286
+4,312
| +5% | +$212K | ﹤0.01% | 1161 |
|
|
2020
Q1 | $3.78M | Sell |
83,974
-8,157
| -9% | -$411K | ﹤0.01% | 1119 |
|
|
2019
Q4 | $4.42M | Buy |
92,131
+52,745
| +134% | +$2.24M | ﹤0.01% | 1432 |
|
|
2019
Q3 | $1.33M | Buy |
39,386
+1,300
| +3% | +$56.6K | ﹤0.01% | 1942 |
|
|
2019
Q2 | $1.71M | Buy |
38,086
+1,511
| +4% | +$59.7K | ﹤0.01% | 1785 |
|
|
2019
Q1 | $1.38M | Sell |
36,575
-2,234
| -6% | -$75K | ﹤0.01% | 1881 |
|
|
2018
Q4 | $1.33M | Buy |
38,809
+37,687
| +3,359% | +$1.36M | ﹤0.01% | 1746 |
|
|
2018
Q3 | $53K | Sell |
1,122
-10
| -0.9% | -$414 | ﹤0.01% | 3370 |
|
|
2018
Q2 | $38K | Buy |
1,132
+322
| +40% | +$10K | ﹤0.01% | 3527 |
|
|
2018
Q1 | $22K | Hold |
810
| – | – | ﹤0.01% | 3531 |
|
|
2017
Q4 | $14K | Sell |
810
-108
| -12% | -$1.83K | ﹤0.01% | 3688 |
|
|
2017
Q3 | $18K | Sell |
918
-26,091
| -97% | -$511K | ﹤0.01% | 3553 |
|
|
2017
Q2 | $495K | Hold |
27,009
| – | – | ﹤0.01% | 2280 |
|
|
2017
Q1 | $266K | Sell |
27,009
-42,249
| -61% | -$511K | ﹤0.01% | 2337 |
|
|
2016
Q4 | $772K | Buy |
69,258
+32,249
| +87% | +$338K | ﹤0.01% | 1983 |
|
|
2016
Q3 | $518K | Buy |
37,009
+10,000
| +37% | +$81.3K | ﹤0.01% | 2077 |
|
|
2016
Q2 | $190K | Buy |
27,009
+25,675
| +1,925% | +$188K | ﹤0.01% | 2495 |
|
|
2016
Q1 | $8K | Sell |
1,334
-14,825
| -92% | -$257K | ﹤0.01% | 3681 |
|
|
2015
Q4 | $523K | Buy |
16,159
+12,949
| +403% | +$381K | ﹤0.01% | 1976 |
|
|
2015
Q3 | $85K | Sell |
3,210
-13,430
| -81% | -$574K | ﹤0.01% | 2704 |
|
|
2015
Q2 | $801K | Buy |
+16,640
| New | +$971K | ﹤0.01% | 1764 |
|
|
2014
Q3 | – | Sell |
-10,290
| Closed | -$269K | – | 4328 |
|
|
2014
Q2 | $269K | Buy |
+10,290
| New | +$220K | ﹤0.01% | 2394 |
|
Other funds holding PTCT
RI
JT
Bank of Montreal's PTCT Position: Q2 2026 in Review
Bank of Montreal increased its PTC Therapeutics (PTCT) stake by 7.4% in Q2 2026, buying an estimated $44.5K and bringing the position to 8,911 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.
Bank of Montreal first reported a position in PTCT in Q2 2014 and has held it in 33 quarters since. The position peaked at $8.13M in Q3 2024. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Bank of Montreal held 8,911 shares of PTC Therapeutics worth $727K as of Q2 2026.
- Bank of Montreal bought 616 PTC Therapeutics shares in Q2 2026, an estimated $44.5K.
- PTC Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2258 holding.
- Bank of Montreal first reported a position in PTC Therapeutics in Q2 2014 and has held it in 33 quarters since.
- Bank of Montreal's PTC Therapeutics position peaked at $8.13M in Q3 2024.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.